Benzinga | Aug 10, 2021 04:24PM EDT

Alpine Immune Sciences Q2 EPS $(0.46) Misses $(0.40) Estimate, Sales $7.19M Beat $6.48M Estimate

Alpine Immune Sciences (NASDAQ:ALPN) reported quarterly losses of $(0.46) per share which missed the analyst consensus estimate of $(0.40) by 15 percent. This is a 13.21 percent increase over losses of $(0.53) per share from the same period last year. The company reported quarterly sales of $7.19 million which beat the analyst consensus estimate of $6.48 million by 11.00 percent. This is a 945.49 percent increase over sales of $688.00 thousand the same period last year.